“INNOVATION IN HEALTHCARE: FROM TECHNOLOGY TO BUSINESS MODELS AND TRANSACTIONS” A Joint Event - Swiss HLG & PLCF Summer Conference, 16th May 2018 Preliminary Program 9:00am - 5:00pm Welcome Note • Gabrielle Gache, President Swiss HLG • Philippe Rozo, President Pharma Licensing Club France • Nigel Sheail, Head of M&A and BD&L at Novartis Featured Speakers and Program • Patrick Aebischer – President emeritus, Brain Mind Institute at EPFL (Keynote Speaker) • Jurgi Camblong –Co-Founder and Chief Executive Officer at Sophia Genetics • Hervé Affagard – Co-Founder and Chief Executive Officer at MaaT Pharma • Panel* around Financing – Moderator: Marc Ceulemans • Vas Narasimhan - Chief Executive Officer at Novartis • Networking Lunch (Buffet/Standing) • Mondher Mahjoubi - Chief Executive Officer at Innate Pharma • Patrick Amstutz – Co-Founder and Chief Executive Officer at Molecular Partners *Panelists - “Financing” Michèle Ollier, Partner at Medicxi Christoph Kausch, Founding Partner and Chief Executive Officer at MTIP Bervin Bouani, Senior Investment Manager at Turenne Capital Marie Petit, Principal at Villiger Valuation Jean-Philippe Tripet, Managing Partner at Aravis Moderator: Marc Ceulemans, Head Strategic Venture Capital Fund at Novartis Registration cost: including Networking Lunch & Breaks Swiss HLG Member and PLCF Member Rate € 130 Non-Member Rate € 150 the number of seats/attendees is limited, register now! TO REGISTER >> https://swisshlg.ngaevents.co.uk/swisshlg-basel/ Use public transport as parking availability is very limited on Novartis Campus (map will be provided once registration completed) This conference is not only an excellent platform for networking with colleagues but also a good place to showcase and attract partners to your organization. For more information and contact details : www.swisshlg.com.